Global Naloxegol Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Naloxegol Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Tablet
  • 1.2.3 Capsule
• 1.3 Market by Application
  • 1.3.1 Global Naloxegol Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Pharmacy
  • 1.3.3 Hospital
  • 1.3.4 Clinic
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Naloxegol Market Perspective (2017-2028)
• 2.2 Naloxegol Growth Trends by Region
  • 2.2.1 Naloxegol Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Naloxegol Historic Market Size by Region (2017-2022)
  • 2.2.3 Naloxegol Forecasted Market Size by Region (2023-2028)
• 2.3 Naloxegol Market Dynamics
  • 2.3.1 Naloxegol Industry Trends
  • 2.3.2 Naloxegol Market Drivers
  • 2.3.3 Naloxegol Market Challenges
  • 2.3.4 Naloxegol Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Naloxegol Players by Revenue
  • 3.1.1 Global Top Naloxegol Players by Revenue (2017-2022)
  • 3.1.2 Global Naloxegol Revenue Market Share by Players (2017-2022)
• 3.2 Global Naloxegol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Naloxegol Revenue
• 3.4 Global Naloxegol Market Concentration Ratio
  • 3.4.1 Global Naloxegol Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Naloxegol Revenue in 2021
• 3.5 Naloxegol Key Players Head office and Area Served
• 3.6 Key Players Naloxegol Product Solution and Service
• 3.7 Date of Enter into Naloxegol Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Naloxegol Breakdown Data by Type

• 4.1 Global Naloxegol Historic Market Size by Type (2017-2022)
• 4.2 Global Naloxegol Forecasted Market Size by Type (2023-2028)

5 Naloxegol Breakdown Data by Application

• 5.1 Global Naloxegol Historic Market Size by Application (2017-2022)
• 5.2 Global Naloxegol Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Naloxegol Market Size (2017-2028)
• 6.2 North America Naloxegol Market Size by Type
  • 6.2.1 North America Naloxegol Market Size by Type (2017-2022)
  • 6.2.2 North America Naloxegol Market Size by Type (2023-2028)
  • 6.2.3 North America Naloxegol Market Share by Type (2017-2028)
• 6.3 North America Naloxegol Market Size by Application
  • 6.3.1 North America Naloxegol Market Size by Application (2017-2022)
  • 6.3.2 North America Naloxegol Market Size by Application (2023-2028)
  • 6.3.3 North America Naloxegol Market Share by Application (2017-2028)
• 6.4 North America Naloxegol Market Size by Country
  • 6.4.1 North America Naloxegol Market Size by Country (2017-2022)
  • 6.4.2 North America Naloxegol Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Naloxegol Market Size (2017-2028)
• 7.2 Europe Naloxegol Market Size by Type
  • 7.2.1 Europe Naloxegol Market Size by Type (2017-2022)
  • 7.2.2 Europe Naloxegol Market Size by Type (2023-2028)
  • 7.2.3 Europe Naloxegol Market Share by Type (2017-2028)
• 7.3 Europe Naloxegol Market Size by Application
  • 7.3.1 Europe Naloxegol Market Size by Application (2017-2022)
  • 7.3.2 Europe Naloxegol Market Size by Application (2023-2028)
  • 7.3.3 Europe Naloxegol Market Share by Application (2017-2028)
• 7.4 Europe Naloxegol Market Size by Country
  • 7.4.1 Europe Naloxegol Market Size by Country (2017-2022)
  • 7.4.2 Europe Naloxegol Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Naloxegol Market Size (2017-2028)
• 8.2 Asia-Pacific Naloxegol Market Size by Type
  • 8.2.1 Asia-Pacific Naloxegol Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Naloxegol Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Naloxegol Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Naloxegol Market Size by Application
  • 8.3.1 Asia-Pacific Naloxegol Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Naloxegol Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Naloxegol Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Naloxegol Market Size by Region
  • 8.4.1 Asia-Pacific Naloxegol Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Naloxegol Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Naloxegol Market Size (2017-2028)
• 9.2 Latin America Naloxegol Market Size by Type
  • 9.2.1 Latin America Naloxegol Market Size by Type (2017-2022)
  • 9.2.2 Latin America Naloxegol Market Size by Type (2023-2028)
  • 9.2.3 Latin America Naloxegol Market Share by Type (2017-2028)
• 9.3 Latin America Naloxegol Market Size by Application
  • 9.3.1 Latin America Naloxegol Market Size by Application (2017-2022)
  • 9.3.2 Latin America Naloxegol Market Size by Application (2023-2028)
  • 9.3.3 Latin America Naloxegol Market Share by Application (2017-2028)
• 9.4 Latin America Naloxegol Market Size by Country
  • 9.4.1 Latin America Naloxegol Market Size by Country (2017-2022)
  • 9.4.2 Latin America Naloxegol Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Naloxegol Market Size (2017-2028)
• 10.2 Middle East & Africa Naloxegol Market Size by Type
  • 10.2.1 Middle East & Africa Naloxegol Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Naloxegol Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Naloxegol Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Naloxegol Market Size by Application
  • 10.3.1 Middle East & Africa Naloxegol Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Naloxegol Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Naloxegol Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Naloxegol Market Size by Country
  • 10.4.1 Middle East & Africa Naloxegol Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Naloxegol Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 MOVANTIK
  • 11.1.1 MOVANTIK Company Details
  • 11.1.2 MOVANTIK Business Overview
  • 11.1.3 MOVANTIK Naloxegol Introduction
  • 11.1.4 MOVANTIK Revenue in Naloxegol Business (2017-2022)
  • 11.1.5 MOVANTIK Recent Developments
• 11.2 AstraZeneca
  • 11.2.1 AstraZeneca Company Details
  • 11.2.2 AstraZeneca Business Overview
  • 11.2.3 AstraZeneca Naloxegol Introduction
  • 11.2.4 AstraZeneca Revenue in Naloxegol Business (2017-2022)
  • 11.2.5 AstraZeneca Recent Developments
• 11.3 Aurobindo
  • 11.3.1 Aurobindo Company Details
  • 11.3.2 Aurobindo Business Overview
  • 11.3.3 Aurobindo Naloxegol Introduction
  • 11.3.4 Aurobindo Revenue in Naloxegol Business (2017-2022)
  • 11.3.5 Aurobindo Recent Developments
• 11.4 MSN Life Sciences
  • 11.4.1 MSN Life Sciences Company Details
  • 11.4.2 MSN Life Sciences Business Overview
  • 11.4.3 MSN Life Sciences Naloxegol Introduction
  • 11.4.4 MSN Life Sciences Revenue in Naloxegol Business (2017-2022)
  • 11.4.5 MSN Life Sciences Recent Developments
• 11.5 Lepu
  • 11.5.1 Lepu Company Details
  • 11.5.2 Lepu Business Overview
  • 11.5.3 Lepu Naloxegol Introduction
  • 11.5.4 Lepu Revenue in Naloxegol Business (2017-2022)
  • 11.5.5 Lepu Recent Developments
• 11.6 Daiichi Sankyo Company
  • 11.6.1 Daiichi Sankyo Company Company Details
  • 11.6.2 Daiichi Sankyo Company Business Overview
  • 11.6.3 Daiichi Sankyo Company Naloxegol Introduction
  • 11.6.4 Daiichi Sankyo Company Revenue in Naloxegol Business (2017-2022)
  • 11.6.5 Daiichi Sankyo Company Recent Developments
• 11.7 Knight Therapeutics
  • 11.7.1 Knight Therapeutics Company Details
  • 11.7.2 Knight Therapeutics Business Overview
  • 11.7.3 Knight Therapeutics Naloxegol Introduction
  • 11.7.4 Knight Therapeutics Revenue in Naloxegol Business (2017-2022)
  • 11.7.5 Knight Therapeutics Recent Developments
• 11.8 Kyowa Kirin International
  • 11.8.1 Kyowa Kirin International Company Details
  • 11.8.2 Kyowa Kirin International Business Overview
  • 11.8.3 Kyowa Kirin International Naloxegol Introduction
  • 11.8.4 Kyowa Kirin International Revenue in Naloxegol Business (2017-2022)
  • 11.8.5 Kyowa Kirin International Recent Developments
• 11.9 Nektar Therapeutics
  • 11.9.1 Nektar Therapeutics Company Details
  • 11.9.2 Nektar Therapeutics Business Overview
  • 11.9.3 Nektar Therapeutics Naloxegol Introduction
  • 11.9.4 Nektar Therapeutics Revenue in Naloxegol Business (2017-2022)
  • 11.9.5 Nektar Therapeutics Recent Developments
• 11.10 RedHill Biopharma Ltd.
  • 11.10.1 RedHill Biopharma Ltd. Company Details
  • 11.10.2 RedHill Biopharma Ltd. Business Overview
  • 11.10.3 RedHill Biopharma Ltd. Naloxegol Introduction
  • 11.10.4 RedHill Biopharma Ltd. Revenue in Naloxegol Business (2017-2022)
  • 11.10.5 RedHill Biopharma Ltd. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

• Table 1. Global Naloxegol Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Tablet
• Table 3. Key Players of Capsule
• Table 4. Global Naloxegol Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 5. Global Naloxegol Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 6. Global Naloxegol Market Size by Region (2017-2022) & (US$ Million)
• Table 7. Global Naloxegol Market Share by Region (2017-2022)
• Table 8. Global Naloxegol Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 9. Global Naloxegol Market Share by Region (2023-2028)
• Table 10. Naloxegol Market Trends
• Table 11. Naloxegol Market Drivers
• Table 12. Naloxegol Market Challenges
• Table 13. Naloxegol Market Restraints
• Table 14. Global Naloxegol Revenue by Players (2017-2022) & (US$ Million)
• Table 15. Global Naloxegol Revenue Share by Players (2017-2022)
• Table 16. Global Top Naloxegol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naloxegol as of 2021)
• Table 17. Ranking of Global Top Naloxegol Companies by Revenue (US$ Million) in 2021
• Table 18. Global 5 Largest Players Market Share by Naloxegol Revenue (CR5 and HHI) & (2017-2022)
• Table 19. Key Players Headquarters and Area Served
• Table 20. Key Players Naloxegol Product Solution and Service
• Table 21. Date of Enter into Naloxegol Market
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Naloxegol Market Size by Type (2017-2022) & (US$ Million)
• Table 24. Global Naloxegol Revenue Market Share by Type (2017-2022)
• Table 25. Global Naloxegol Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 26. Global Naloxegol Revenue Market Share by Type (2023-2028)
• Table 27. Global Naloxegol Market Size by Application (2017-2022) & (US$ Million)
• Table 28. Global Naloxegol Revenue Share by Application (2017-2022)
• Table 29. Global Naloxegol Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 30. Global Naloxegol Revenue Share by Application (2023-2028)
• Table 31. North America Naloxegol Market Size by Type (2017-2022) & (US$ Million)
• Table 32. North America Naloxegol Market Size by Type (2023-2028) & (US$ Million)
• Table 33. North America Naloxegol Market Size by Application (2017-2022) & (US$ Million)
• Table 34. North America Naloxegol Market Size by Application (2023-2028) & (US$ Million)
• Table 35. North America Naloxegol Market Size by Country (2017-2022) & (US$ Million)
• Table 36. North America Naloxegol Market Size by Country (2023-2028) & (US$ Million)
• Table 37. Europe Naloxegol Market Size by Type (2017-2022) & (US$ Million)
• Table 38. Europe Naloxegol Market Size by Type (2023-2028) & (US$ Million)
• Table 39. Europe Naloxegol Market Size by Application (2017-2022) & (US$ Million)
• Table 40. Europe Naloxegol Market Size by Application (2023-2028) & (US$ Million)
• Table 41. Europe Naloxegol Market Size by Country (2017-2022) & (US$ Million)
• Table 42. Europe Naloxegol Market Size by Country (2023-2028) & (US$ Million)
• Table 43. Asia Pacific Naloxegol Market Size by Type (2017-2022) & (US$ Million)
• Table 44. Asia Pacific Naloxegol Market Size by Type (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Naloxegol Market Size by Application (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Naloxegol Market Size by Application (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Naloxegol Market Size by Region (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Naloxegol Market Size by Region (2023-2028) & (US$ Million)
• Table 49. Latin America Naloxegol Market Size by Type (2017-2022) & (US$ Million)
• Table 50. Latin America Naloxegol Market Size by Type (2023-2028) & (US$ Million)
• Table 51. Latin America Naloxegol Market Size by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Naloxegol Market Size by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Naloxegol Market Size by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Naloxegol Market Size by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Naloxegol Market Size by Type (2017-2022) & (US$ Million)
• Table 56. Middle East and Africa Naloxegol Market Size by Type (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Naloxegol Market Size by Application (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Naloxegol Market Size by Application (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Naloxegol Market Size by Country (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Naloxegol Market Size by Country (2023-2028) & (US$ Million)
• Table 61. MOVANTIK Company Details
• Table 62. MOVANTIK Business Overview
• Table 63. MOVANTIK Naloxegol Product
• Table 64. MOVANTIK Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 65. MOVANTIK Recent Developments
• Table 66. AstraZeneca Company Details
• Table 67. AstraZeneca Business Overview
• Table 68. AstraZeneca Naloxegol Product
• Table 69. AstraZeneca Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 70. AstraZeneca Recent Developments
• Table 71. Aurobindo Company Details
• Table 72. Aurobindo Business Overview
• Table 73. Aurobindo Naloxegol Product
• Table 74. Aurobindo Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 75. Aurobindo Recent Developments
• Table 76. MSN Life Sciences Company Details
• Table 77. MSN Life Sciences Business Overview
• Table 78. MSN Life Sciences Naloxegol Product
• Table 79. MSN Life Sciences Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 80. MSN Life Sciences Recent Developments
• Table 81. Lepu Company Details
• Table 82. Lepu Business Overview
• Table 83. Lepu Naloxegol Product
• Table 84. Lepu Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 85. Lepu Recent Developments
• Table 86. Daiichi Sankyo Company Company Details
• Table 87. Daiichi Sankyo Company Business Overview
• Table 88. Daiichi Sankyo Company Naloxegol Product
• Table 89. Daiichi Sankyo Company Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 90. Daiichi Sankyo Company Recent Developments
• Table 91. Knight Therapeutics Company Details
• Table 92. Knight Therapeutics Business Overview
• Table 93. Knight Therapeutics Naloxegol Product
• Table 94. Knight Therapeutics Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 95. Knight Therapeutics Recent Developments
• Table 96. Kyowa Kirin International Company Details
• Table 97. Kyowa Kirin International Business Overview
• Table 98. Kyowa Kirin International Naloxegol Product
• Table 99. Kyowa Kirin International Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 100. Kyowa Kirin International Recent Developments
• Table 101. Nektar Therapeutics Company Details
• Table 102. Nektar Therapeutics Business Overview
• Table 103. Nektar Therapeutics Naloxegol Product
• Table 104. Nektar Therapeutics Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 105. Nektar Therapeutics Recent Developments
• Table 106. RedHill Biopharma Ltd. Company Details
• Table 107. RedHill Biopharma Ltd. Business Overview
• Table 108. RedHill Biopharma Ltd. Naloxegol Product
• Table 109. RedHill Biopharma Ltd. Revenue in Naloxegol Business (2017-2022) & (US$ Million)
• Table 110. RedHill Biopharma Ltd. Recent Developments
• Table 111. Research Programs/Design for This Report
• Table 112. Key Data Information from Secondary Sources
• Table 113. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Naloxegol Market Share by Type: 2021 VS 2028
• Figure 2. Tablet Features
• Figure 3. Capsule Features
• Figure 4. Global Naloxegol Market Share by Application: 2021 VS 2028
• Figure 5. Pharmacy Case Studies
• Figure 6. Hospital Case Studies
• Figure 7. Clinic Case Studies
• Figure 8. Others Case Studies
• Figure 9. Naloxegol Report Years Considered
• Figure 10. Global Naloxegol Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 11. Global Naloxegol Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Naloxegol Market Share by Region: 2021 VS 2028
• Figure 13. Global Naloxegol Market Share by Players in 2021
• Figure 14. Global Top Naloxegol Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naloxegol as of 2021)
• Figure 15. The Top 10 and 5 Players Market Share by Naloxegol Revenue in 2021
• Figure 16. North America Naloxegol Market Size YoY (2017-2028) & (US$ Million)
• Figure 17. North America Naloxegol Market Size Market Share by Type (2017-2028)
• Figure 18. North America Naloxegol Market Size Market Share by Application (2017-2028)
• Figure 19. North America Naloxegol Market Size Share by Country (2017-2028)
• Figure 20. United States Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Canada Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 22. Europe Naloxegol Market Size YoY (2017-2028) & (US$ Million)
• Figure 23. Europe Naloxegol Market Size Market Share by Type (2017-2028)
• Figure 24. Europe Naloxegol Market Size Market Share by Application (2017-2028)
• Figure 25. Europe Naloxegol Market Size Share by Country (2017-2028)
• Figure 26. Germany Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. France Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. U.K. Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Italy Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Russia Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Nordic Countries Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Asia-Pacific Naloxegol Market Size YoY (2017-2028) & (US$ Million)
• Figure 33. Asia Pacific Naloxegol Market Size Market Share by Type (2017-2028)
• Figure 34. Asia Pacific Naloxegol Market Size Market Share by Application (2017-2028)
• Figure 35. Asia Pacific Naloxegol Market Size Share by Region (2017-2028)
• Figure 36. China Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Japan Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. South Korea Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Southeast Asia Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. India Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Australia Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. Latin America Naloxegol Market Size YoY (2017-2028) & (US$ Million)
• Figure 43. Latin America Naloxegol Market Size Market Share by Type (2017-2028)
• Figure 44. Latin America Naloxegol Market Size Market Share by Application (2017-2028)
• Figure 45. Latin America Naloxegol Market Size Share by Country (2017-2028)
• Figure 46. Mexico Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Brazil Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 48. Middle East & Africa Naloxegol Market Size YoY (2017-2028) & (US$ Million)
• Figure 49. Middle East and Africa Naloxegol Market Size Market Share by Type (2017-2028)
• Figure 50. Middle East and Africa Naloxegol Market Size Market Share by Application (2017-2028)
• Figure 51. Middle East and Africa Naloxegol Market Size Share by Country (2017-2028)
• Figure 52. Turkey Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Saudi Arabia Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. UAE Naloxegol Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. MOVANTIK Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 56. AstraZeneca Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 57. Aurobindo Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 58. MSN Life Sciences Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 59. Lepu Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 60. Daiichi Sankyo Company Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 61. Knight Therapeutics Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 62. Kyowa Kirin International Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 63. Nektar Therapeutics Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 64. RedHill Biopharma Ltd. Revenue Growth Rate in Naloxegol Business (2017-2022)
• Figure 65. Bottom-up and Top-down Approaches for This Report
• Figure 66. Data Triangulation
• Figure 67. Key Executives Interviewed